Genetic polymorphisms of innate immunity-related inflammatory pathways and their association with factors related to type 2 diabetes
Authors:
- Paul AroraPAPaul Arora
- Bibiana Garcia-BailoBGBibiana Garcia-Bailo
- Zari DastaniZDZari Dastani
- Darren BrennerDBDarren Brenner
- Andre VillegasAVAndre Villegas
- Suneil MalikSMSuneil Malik
- Timothy D SpectorTSTimothy D Spector
- Brent RichardsBRBrent Richards
- Ahmed El-SohemyAhmed El-Sohemy
- Mohamed KarmaliMKMohamed Karmali
- Alaa BadawiABAlaa Badawi
Open Access
- 14 July 2011
- journal article
- research article
- Published by Springer Nature in BMC Medical Genetics
- Vol. 12 (1) , 95
Abstract
Background: Type 2 diabetes mellitus (T2DM) has been linked to a state of pre-clinical chronic inflammation resulting from abnormalities in the innate immune pathway. Serum levels of pro-inflammatory cytokines and acute-phase proteins, collectively known as 'inflammatory network', are elevated in the pre-, or early, stages of T2DM and increase with disease progression. Genetic variation can affect the innate immune response to certain environmental factors, and may, therefore, determine an individual's lifetime risk of disease.Methods: We conducted a cross-sectional study in 6,720 subjects from the TwinsUK Registry to evaluate the association between 18 single nucleotide polymorphisms (SNPs) in five genes (TLR4,IL1A,IL6,TNFA, andCRP) along the innate immunity-related inflammatory pathway and biomarkers of predisposition to T2DM [fasting insulin and glucose, HDL- and LDL- cholesterols, triglycerides (TGs), amyloid-A, sensitive C-reactive protein (sCRP) and vitamin D binding protein (VDBP) and body mass index (BMI)].Results: Of 18 the SNPs examined for their association with nine metabolic phenotypes of interest, six were significantly associated with five metabolic phenotypes (Bonferroni correction,P ≤ 0.0027). Fasting insulin was associated with SNPs inIL6andTNFA, serum HDL-C with variants ofTNFAandCRPand serum sCRP level with SNPs inCRP. Cross-correlation analysis among the different metabolic factors related to risk of T2DM showed several significant associations. For example, BMI was directly correlated with glucose (r = 0.11), insulin (r = 0.15), sCRP (r = 0.23), LDL-C (r = 0.067) and TGs (r = 0.18) but inversely with HDL-C (r = -0.14). sCRP was also positively correlated (P < 0.0001) with insulin (r = 0.17), amyloid-A (r = 0.39), TGs (r = 0.26), and VDBP (r = 0.36) but inversely with HDL-C (r = -0.12).Conclusion: Genetic variants in the innate immunity pathway and its related inflammatory cascade is associated with some metabolic risk factors for T2DM; an observation that may provide a rationale for further studying their role as biomarkers for disease early risk prediction.Keywords
This publication has 69 references indexed in Scilit:
- Candidate loci for insulin sensitivity and disposition index from a genome-wide association analysis of Hispanic participants in the Insulin Resistance Atherosclerosis (IRAS) Family StudyDiabetologia, 2009
- Bayesian mixture modeling of gene‐environment and gene‐gene interactionsGenetic Epidemiology, 2009
- Genome-wide association with select biomarker traits in the Framingham Heart StudyBMC Medical Genetics, 2007
- Obesity induces a phenotypic switch in adipose tissue macrophage polarizationJournal of Clinical Investigation, 2007
- Inflammation and metabolic disordersNature, 2006
- Inflammation and insulin resistanceJournal of Clinical Investigation, 2006
- Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetesDiabetologia, 2005
- The International HapMap ProjectNature, 2003
- Cytokine gene polymorphism in human disease: on-line databases, Supplement 2Genes & Immunity, 2002
- Global and societal implications of the diabetes epidemicNature, 2001